Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors.
about
Adenosine receptors as therapeutic targetsPyran Template Approach to the Design of Novel A3 Adenosine Receptor AntagonistsQuinazolines as adenosine receptor antagonists: SAR and selectivity for A2B receptors.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsCharacterization of the A2B adenosine receptor from mouse, rabbit, and dog.Adenosine and ischemic preconditioning.A2A adenosine receptor protects tumors from antitumor T cells.Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition processHuman breast cancer cell line MDA-MB-231 expresses endogenous A2B adenosine receptors mediating a Ca2+ signal.Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome.Introduction to adenosine receptors as therapeutic targets.Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.Synthesis and biological evaluation of a new series of 1,2,4-triazolo[1,5-a]-1,3,5-triazines as human A(2A) adenosine receptor antagonists with improved water solubility.Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum.A1R-A2AR heteromers coupled to Gs and G i/0 proteins modulate GABA transport into astrocytes.Characterization of human and rodent native and recombinant adenosine A(2B) receptors by radioligand binding studies.Regulation of adenosine receptor subtypes during cultivation of human monocytes: role of receptors in preventing lipopolysaccharide-triggered respiratory burst.The utilization of a unified pharmacophore query in the discovery of new antagonists of the adenosine receptor family.[3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors.
P2860
Q24632095-74177F99-9BA9-4202-A0C3-7594FD26968AQ28834245-E18AB4A9-3515-4B33-8A2E-CDD8BF1A9094Q30424843-B64FFC03-A369-41ED-B135-E0CA04285341Q30486707-3C572D10-8B24-4141-8161-6ED6B5A5F9DDQ33399655-FB73D41C-BBE5-4CC2-B7AA-0D88E1D7BC0FQ33801903-7CC0A55A-4057-40C8-B792-65C62B924F1DQ35016529-10B35051-0952-414F-B0E2-A24E03B9CE81Q35020369-989EC449-C5D3-478F-BDC4-3227E764DA63Q35048860-711F08A0-C7A5-4F23-AE07-F665DB33D566Q35662894-9824DCCA-A472-4FE9-A233-6B3828408016Q36153376-072AAAC8-70C4-4206-B8AE-D7CE8AC8EA9CQ36316924-5C469637-7092-45E3-83F3-582CFD30DCECQ36626953-6A291DD0-CD77-45DB-8C53-88F261A0A9D3Q37046788-1B020E0E-86C2-4365-A516-E278B00E77A8Q37131945-4B551ACE-3C9E-4A87-8513-471C7565815CQ39992970-97642D84-AA04-42F9-BB28-5D7EB5B5E1E1Q40634372-255A7AF1-C755-4CFF-942C-1738C6F65BB9Q41356420-E4FABAE7-7B14-42E5-B75E-78070280A178Q41493791-5D3BADB8-7CBB-4550-BBA4-92778D6CDF2F
P2860
Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Use of the triazolotriazine [3 ...... human A2B adenosine receptors
@nl
Use of the triazolotriazine [3 ...... human A2B adenosine receptors.
@ast
Use of the triazolotriazine [3 ...... human A2B adenosine receptors.
@en
type
label
Use of the triazolotriazine [3 ...... human A2B adenosine receptors
@nl
Use of the triazolotriazine [3 ...... human A2B adenosine receptors.
@ast
Use of the triazolotriazine [3 ...... human A2B adenosine receptors.
@en
prefLabel
Use of the triazolotriazine [3 ...... human A2B adenosine receptors
@nl
Use of the triazolotriazine [3 ...... human A2B adenosine receptors.
@ast
Use of the triazolotriazine [3 ...... human A2B adenosine receptors.
@en
P2860
P1476
Use of the triazolotriazine [3 ...... human A2B adenosine receptors.
@en
P2093
P2860
P304
P407
P577
1999-11-01T00:00:00Z